TG Therapeutics
TGTX
TGTX
113 hedge funds and large institutions have $387M invested in TG Therapeutics in 2019 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 37 increasing their positions, 29 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 115 → 113 (-2)
4.27% less ownership
Funds ownership: 58.98% → 54.7% (-4.3%)
Holders
113
Holding in Top 10
1
Calls
$19.4M
Puts
$12.1M
Top Buyers
| 1 | +$38.5M | |
| 2 | +$11.2M | |
| 3 | +$10.3M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$6.56M |
| 5 |
EP
Eversept Partners
New York
|
+$5.5M |
Top Sellers
| 1 | -$19.5M | |
| 2 | -$12.3M | |
| 3 | -$8.57M | |
| 4 |
Renaissance Technologies
New York
|
-$6.68M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$6.09M |